Massachusetts General Hospital Launches Phase 2 Trial of BCG Vaccine to Reverse Type 1 Diabetes

A phase 2 clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA).

Source: www.dddmag.com

---